Bevacizumab for Neovascular Age-related Macular Degeneration

NCT01306591 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Exudative Age-related Macular Degeneration

Interventions

DRUG: Bevacizumab 1
DRUG: Bevacizumab

Sponsor

Peking University People's Hospital